MedTech Dive · Jul 22, 2026
Whoop hires FDA digital health committee chair as chief medical officer
Ami Bhatt is joining the company as it makes a broader push into health.
Medical Technology · page 7
Devices, digital health, and the technology changing how care is delivered.
MedTech Dive · Jul 22, 2026
Time runs out for Vicarious Surgical
Shareholders approved a plan to dissolve the robot developer, at one time a well-financed contender to challenge surgical robotics leader Intuitive, and liquidate its assets.
FDA Newsroom · Jul 22, 2026
FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot
The U.S. Food and Drug Administration today announced the first manufacturer selected for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot.
MedTech Dive · Jul 22, 2026
J&J gets FDA authorization for Ottava robot, teeing up competition with Intuitive
While Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery system will take meaningful share from the market leader.
Fierce Biotech · Jul 22, 2026
NIH joins Trump’s $5B AI mission with biomedical research push
The U.S. Department of Health and Human Services announced new efforts Wednesday aligned with President Donald Trump’s artificial intelligence-driven Genesis Mission. The centerpiece of HHS’ participation is the NIH-led Bio Genesis Mission
MedCity News · Jul 22, 2026
Hidden in Plain Sight: The Cost Crisis in Women’s Healthcare
Women have to navigate the fragmented system with very little support, coordinating between providers and often interpreting conflicting guidance. The post Hidden in Plain Sight: The Cost Crisis in Women’s Healthcare appeared first on MedCity News .
MedTech Dive · Jul 22, 2026
Cardinal inks 2 acquisitions in bid to expand at-home services
The company agreed to buy a diabetes health business and medical supplier Strive Medical to boost its growing in-home solutions unit.
MedCity News · Jul 22, 2026
Better Prescribing, Not Less Prescribing, Is What Behavioral Health Needs
The policy conversation needs to shift from just deprescribing alone to building the clinical infrastructure that delivers consistent, high-quality behavioral health care. The post Better Prescribing, Not Less Prescribing, Is What Behavioral Health Needs appeared first on MedCity News .
Fierce Biotech · Jul 22, 2026
House passes bill directing FDA to update animal testing rules
The U.S. House of Representatives passed the FDA Modernization Act 3.0 this week, and lawmakers and animal welfare advocates are celebrating the bill as a step toward a new era in preclinical testing and drug development.
Fierce Biotech · Jul 22, 2026
Royalty Pharma pens $425M deal for slice of sales on AstraZeneca’s ATTR drug
Royalty Pharma has secured a stake in another transthyretin-mediated amyloidosis drug, this time paying $125 million upfront to Neurimmune for a cut of the sales of its AstraZeneca-partnered med.
MedCity News · Jul 21, 2026
New Bill Seeks to Create Public Option on ACA Marketplaces
Rep. Angie Craig introduced a bill to establish a public health insurance option on the ACA marketplaces and permanently extend enhanced premium tax credits. The post New Bill Seeks to Create Public Option on ACA Marketplaces appeared first on MedCity News .
MedTech Dive · Jul 21, 2026
Philips wins FDA clearance for new pulse oximeter
Philips said its updated device provides accurate readings across a range of skin tones, following concerns that pulse oximeters can be less accurate in people with darker skin pigmentation.
Fierce Biotech · Jul 21, 2026
‘We’re moving quickly’: Startup bags rare disease drug as Thiel-backed CEO eyes $50M fundraise
A rare disease startup with a mission to repurpose proven drugs has licensed a Chinese formulation of a well-known medicine and set its sights on a $50 million fundraise.
Fierce Biotech · Jul 21, 2026
Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge
A group of 61 biopharma companies, executives and investors has filed an amicus brief in support of the FDA in an ongoing case brought by Louisiana meant to remove access to the abortion pill mifepristone.
MedTech Dive · Jul 21, 2026
Medtronic adds real-time AI to Hugo robot
The computing platform will make its debut at the Society of Robotic Surgery meeting this week, as Medtronic challenges Intuitive in the U.S. robotic soft tissue market.
MedCity News · Jul 21, 2026
How Diagnostic Precision in Allergy Care Supports Mental Well-Being
Screening for mental health symptoms in patients with significant allergic disease is not overreach The post How Diagnostic Precision in Allergy Care Supports Mental Well-Being appeared first on MedCity News .
MedCity News · Jul 21, 2026
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction. The post Why Pharma Companies Should Look To Social Media For Better Patient Insight appeared first on MedCity News .
Fierce Biotech · Jul 21, 2026
‘We’ve been looking for a novel approach’: Why Novartis CEO ended ADC holdout for $1.5B Myricx deal
For years, as Big Pharma poured billions into ADCs, Novartis CEO Vas Narasimhan notably stayed on the sidelines. Asked by Fierce during Novartis’ Q2 earnings call, Narasimhan explained why he is ending that holdout with the proposed $1.5 billion deal for Myricx.
Fierce Biotech · Jul 21, 2026
Jupiter enters psychedelics space with $100M deal for PharmAla's MDMA drug
Jupiter Neurosciences will pay $3.3 million upfront to Canada's PharmAla Biotech for U.S. rights to an MDMA drug to treat neuropsychiatric disorders.
MedTech Dive · Jul 21, 2026
GE HealthCare inks 10-year, $500M alliance with Catholic Health
The deal is the latest in a series of pacts that GE HealthCare has made with health systems, including with Sutter Health and UC San Diego.
Fierce Biotech · Jul 21, 2026
Indian generics maker Lupin seeds US spinout Kaveri with cash, clinical-phase cancer assets
Lupin has spun out two clinical-phase cancer drug candidates to create Kaveri Therapeutics, a U.S.-based startup that plans to raise cash for further development. Kaveri’s programs hit targets pursued by major drugmakers including AstraZeneca, Bayer and Bristol Myers Squibb.
Fierce Biotech · Jul 21, 2026
Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial role
Dan Malarek is leaving his role as chief executive of Roche’s sequencing subsidiary Foundation Medicine as he takes up the mantle as President and CEO of Roche Diagnostics North America.
MedCity News · Jul 20, 2026
The Same AI That Helps Patients Is Being Used to Attack Them, Hospital Exec Says
As hospitals increasingly use AI to improve patient care, the same technology is being used by hackers and nation-states to launch faster, more sophisticated attacks. Karen Habercoss, chief information security and privacy officer at the University of Chicago Medicine, explained how her health system is building a governance structure to manage that risk. The post The Same AI That Helps Patients Is Being Used to Attack Them, Hospital Exec Says appeared first on MedCity News .
MedCity News · Jul 20, 2026
How Should Clinical AI Be Paid For? 3 Takeaways
A new report from the Peterson Health Technology Institute argues that today’s healthcare payment models are ill-suited for clinical AI and could drive up costs. The post How Should Clinical AI Be Paid For? 3 Takeaways appeared first on MedCity News .